Phreesia, Inc. (PHR) Interactive Stock Chart
This page provides an interactive stock chart and related financial information for Phreesia, Inc. (PHR) on Yahoo Finance. It displays the current stock price, recent news articles about the company, and links to various financial data points. The stock is currently trading at $10.15, down 2.08% as of 1:59 PM EDT.
Phreesia, Inc. (PHR) stock price, news, quote and history
This Yahoo Finance page provides comprehensive information on Phreesia, Inc. (PHR) stock, including its current price, historical data, key financial metrics, and analyst insights. The company offers a SaaS-based software and payment platform for the healthcare industry, utilizing AI-enabled solutions for patient intake, communication, and payment processing. The article also details performance overview, earnings trends, and recent analyst ratings for PHR.
Phreesia (PHR) ties its accounting officer’s stock award to share-price targets through 2031
Phreesia, Inc. has granted its Principal Accounting Officer, Yvonne Hui, 28,500 performance stock units (PSUs) on September 1, 2026. The actual number of shares Hui will receive is contingent on Phreesia's stock price meeting specific hurdles ($17.00, $22.00, $27.00, and $32.00) over a 60-trading-day period between September 2026 and September 2031, with potential payouts ranging from 0% to 200% of the target. Earned units will vest in three installments, subject to continued service, and are outlined in a recent Form 4 SEC filing.
Up to twice the target: Phreesia (NYSE: PHR) ties an HR executive's stock award to share-price hurdles
Phreesia, Inc. has awarded its SVP, Human Resources, Amy Beth VanDuyn, 67,500 target performance stock units. The actual number of shares earned will depend on Phreesia's stock price reaching specific hurdles of $17.00, $22.00, $27.00, and $32.00 per share by September 1, 2031, with potential payouts ranging from zero to 200% of the target. Earned units will vest in thirds upon certification and on two anniversaries, subject to continued service.
A CEO stock award could pay 200% of target if Phreesia (PHR) shares meet a price hurdle.
Phreesia (PHR) has granted its CEO, Chaim Indig, a performance stock unit award at a target level of 400,000 PSUs, where each unit represents a contingent right to receive one common share. The actual payout can range from 0% to 200% of the target, depending on whether the company's stock price achieves hurdles of $17.00, $22.00, $27.00, and $32.00 per share over a 60-trading-day period within the performance period ending September 1, 2031. Earned PSUs will vest in thirds upon certification and on the first two anniversaries, contingent on continued service.
Form 4 Phreesia Inc For: 28 September By Investing.com
This article reports on the filing of Form 4 by Phreesia Inc. for September 28th, as published by Investing.com. The content is brief, primarily serving as an announcement of the filing with no additional details provided within the main text. It indicates that PHR's stock experienced a -0.79% change.
Form 4 Phreesia Inc For: 28 September By Investing.com
This article reports on the filing of Form 4 by Phreesia Inc. for September 28. It is a brief announcement from Investing.com, providing basic information about the company and the date of the filing.
A stock-price test could double a Phreesia (PHR) executive's target share award over five years.
Phreesia (PHR) President, Network Solutions David Linetsky, received a target award of 155,000 performance stock units (PSUs) on September 1, 2026. The payout for these PSUs, which can range from 0% to 200% of the target, is contingent upon the company's stock reaching specific price hurdles over a five-year performance period. This incentive aims to align executive compensation with the company's stock performance, motivating the achievement of higher share prices.
Form 4 Phreesia Inc For: 27 September By Investing.com
This article from Investing.com reports on a Form 4 filing for Phreesia Inc, specifically for September 27. It indicates routine financial market news related to insider transactions for the company. The content also features various market data and news headlines beyond the specific Form 4 announcement.
Form 4 Phreesia Inc For: 27 September By Investing.com
This article announces the filing of Form 4 for Phreesia Inc. on September 27th, as reported by Investing.com. It is a brief, content-light update indicating an insider transaction or change in beneficial ownership for the company. The article contains no further details beyond this announcement.
Phreesia general counsel Allison Hoffman disposes of $67k in stock
Phreesia's General Counsel, Allison Hoffman, sold 6,662 shares of the company's common stock for $67,152 on September 21, 2026, under a pre-arranged trading plan. Additionally, 7,401 shares were withheld for tax obligations related to restricted stock units. Despite these transactions, Hoffman still beneficially owns 266,574 shares, and analysts predict Phreesia will be profitable this year, though some have adjusted price targets due to slowing revenue growth.
Phreesia SVP Amy VanDuyn Reports RSU Tax Withholding on Form 4 Filing
Amy Beth VanDuyn, Senior Vice President of Human Resources at Phreesia, Inc. (NYSE:PHR), filed a Form 4 detailing the disposition of 2,876 shares of Common Stock. This transaction, dated September 18, 2026, was not a sale but represented shares withheld by Phreesia to cover tax withholding obligations related to the settlement of restricted stock units (RSUs). After this event, VanDuyn directly holds 260,521 shares of Common Stock.
Phreesia (NYSE: PHR) HR chief reports 2,876-share tax withholding
Phreesia's SVP of Human Resources, Amy Beth VanDuyn, had 2,876 shares of common stock withheld on September 18, 2026, to cover tax obligations related to restricted stock unit settlements. This action was not an open-market sale, and VanDuyn now directly holds 260,521 shares of Phreesia. The reported per-share value for the withheld shares was $10.42.
Phreesia (PHR) president has 4,476 shares withheld for taxes
Phreesia, Inc. (PHR) President of Provider Solutions, Evan Roberts, had 4,476 shares of common stock withheld on September 18, 2026, to cover tax withholding obligations related to restricted stock units. This transaction was not an open-market sale, and Roberts retained 1,038,138 shares directly afterward. The shares were valued at $10.42 each for the withholding process.
Form 4 Phreesia Inc For: 22 September By Investing.com
This article from Investing.com reports on a Form 4 filing for Phreesia Inc (PHR) on September 22, 2026. Form 4 filings typically disclose changes in beneficial ownership of a company's securities by insiders. The article indicates that Phreesia Inc's stock (PHR) was up 3.31%.
Planned Phreesia (NYSE: PHR) insider stock sale tops $67K
Allison C. Hoffman, an insider at Phreesia, Inc. (PHR), has filed a Rule 144 notice for the planned sale of 6,662 shares of common stock. The sale, valued at approximately $67,152.96, is scheduled for September 21, 2026, through Fidelity Brokerage Services LLC. These shares are related to restricted stock that vested on September 14, 2026, and are being sold for compensation-related purposes.
Wall Street Splits on Phreesia (PHR) as Margins Improve but Growth Visibility Fades
Phreesia (PHR) reported improved Q2 fiscal 2027 results with 10% revenue growth and a significant increase in adjusted EBITDA, leading to debt retirement. Despite these positive financial indicators, Wall Street analysts are divided due to concerns over slowing growth, increased AI spending, and reduced visibility in future revenue forecasting. While some firms raised price targets acknowledging margin improvements and cash flow, others downgraded the stock citing elevated risks.
Phreesia's Evan Roberts Converts Half of Cash Bonus into 8,113 RSUs
Evan Roberts, President of Provider Solutions at Phreesia, Inc. (NYSE:PHR), acquired 8,113 restricted stock units (RSUs) on September 14, 2026. These RSUs represent 50% of his cash bonus for the first half of the fiscal year, converted at a 115% premium. Following this transaction, Roberts directly owns 1,042,614 shares of Phreesia common stock.
PHR Investors Have Opportunity to Lead Phreesia, Inc. Securities Fraud Lawsuit with the Schall Law Firm
The Schall Law Firm is reminding investors of a class action lawsuit against Phreesia, Inc. (NYSE: PHR) for alleged securities fraud. Investors who purchased shares between May 8, 2025, and March 30, 2026, are encouraged to contact the firm by July 13, 2026, to potentially lead the lawsuit. The lawsuit claims Phreesia made false and misleading statements about its growth outlook and pharmaceutical marketing commitments.
Raymond James downgrades Phreesia stock rating on slowing growth By Investing.com
Raymond James downgraded Phreesia Inc. (NYSE:PHR) to Market Perform from Outperform due to concerns about decelerating organic revenue growth, which is estimated to turn negative in the second half of fiscal 2027. The firm also cited uncertainty regarding Phreesia's AI investments, the challenging environment for its healthcare clients, and frequent shifts in the company's long-term strategy. Despite the stock appearing undervalued by InvestingPro analysis, Raymond James believes the market is not rewarding healthcare IT companies with low growth profiles.
These Analysts Revise Their Forecasts On Phreesia After Q2 Results
Phreesia Inc (NYSE: PHR) reported mixed Q2 financial results, missing EPS estimates but exceeding sales forecasts. Following the announcement, analysts from Wells Fargo, Needham, and RBC Capital revised their price targets and reiterated their ratings on the stock. Phreesia also reaffirmed its FY2027 sales guidance.
Wells Fargo raises Phreesia stock price target on network growth
Wells Fargo has increased its price target for Phreesia Inc. (NYSE:PHR) to $10.00 from $9.00, maintaining an Equal Weight rating, following the company's strong second-quarter fiscal 2027 results that exceeded EBITDA projections. The healthcare software company demonstrated 9% year-over-year growth in its Network segment, driven by a successful ProviderConnect pilot, despite a 2% decline in subscription revenue. Analysts anticipate Phreesia will achieve profitability this year, with expected net income growth, as highlighted by InvestingPro Tips.
Phreesia Q2 Earnings Call Highlights
Phreesia reported solid fiscal Q2 2027 results with revenue up 10% year-over-year to $129.5 million and adjusted EBITDA reaching $32.9 million, marking its fifth consecutive profitable quarter. The company generated strong cash flow, reducing debt by over $23 million, and reaffirmed its full-year fiscal 2027 guidance, expecting continued growth from AccessOne and ProviderConnect. Phreesia also highlighted its focus on delivering value to healthcare providers amidst financial pressures and integrating AI across its operations.
Here's how to file a claim for the ConnectOnCall $4.95 million data breach settlement
Individuals impacted by the ConnectOnCall data breach between February 16, 2024, and May 12, 2024, may be eligible to claim up to $5,000 from a $4.95 million class action settlement. Class members can receive cash payments for documented losses up to $5,000, or an alternate cash payment of up to $75, and two years of medical identity monitoring. Claims must be submitted by November 2, 2026.
Tocqueville Asset Management L.P. Acquires New Stake in Phreesia, Inc. $PHR
Tocqueville Asset Management L.P. has acquired a new stake in Phreesia, Inc. (NYSE:PHR), purchasing 325,000 shares valued at approximately $3.34 million. This acquisition gives Tocqueville a 0.53% stake in the company, with institutional investors collectively owning 92.10% of Phreesia. Analysts have a mixed sentiment on the stock, with a consensus "Hold" rating and an average price target of $16.65, while Phreesia recently exceeded quarterly revenue and earnings expectations.
PHR INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announce
Bronstein, Gewirtz & Grossman, LLC has announced a class action lawsuit against Phreesia, Inc. (NYSE: PHR) on behalf of investors who suffered losses between May 8, 2025, and March 30, 2026. The lawsuit alleges that Phreesia made false and misleading statements regarding slowing demand, diminished visibility into key revenue streams, and weakened pharmaceutical marketing commitments in its Network Solutions segment. Investors who incurred losses are encouraged to join the lawsuit, with a deadline of July 13, 2026, to request lead plaintiff appointment.
Flputnam Investment Management Co. Takes $1.66 Million Position in Phreesia, Inc. $PHR
Flputnam Investment Management Co. has acquired a new stake of 160,903 shares in Phreesia, Inc. (NYSE:PHR), valued at approximately $1.66 million, giving it a 0.26% ownership. This move comes as Phreesia shows mixed analyst sentiment, with an average "Hold" rating, but exceeded its Q1 earnings and revenue expectations. The company, which provides patient intake management solutions, has a market capitalization of $713.31 million.
Phreesia (NYSE: PHR) executive has 182 RSU shares withheld
Phreesia, Inc. executive David Linetsky, President, Network Solutions, reported a Form 4 detailing the withholding of 182 shares of common stock at $12.28 per share to cover tax obligations related to Restricted Stock Units. This transaction, dated August 14, 2026, was not an open-market sale. Following the withholding, Linetsky's spouse indirectly holds 11,883 shares, and he directly holds 224,056 shares.
Phreesia, Inc. (PHR) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Phreesia, Inc. (NYSE: PHR) securities. The investigation concerns whether Phreesia and its officers and/or directors engaged in corporate wrongdoing. Investors who bought Phreesia securities before March 30, 2026, and still hold them, are encouraged to contact the firm for more information.
PHR SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Phreesia, Inc. Shareholders with Losses Have Opportunity to Lead Class Action Lawsuit!
Bronstein, Gewirtz and Grossman, LLC has announced a class action lawsuit against Phreesia, Inc. (NYSE:PHR) for alleged violations of federal securities laws. The lawsuit claims that Phreesia made false and misleading statements regarding slowing demand, diminished visibility into revenue streams, and weakened pharmaceutical marketing commitments in its Network Solutions segment during the Class Period from May 8, 2025, to March 30, 2026. Shareholders who suffered losses are encouraged to join the lawsuit and have until July 13, 2026, to apply to be lead plaintiff.
Phreesia, Inc. (NYSE:PHR) Given Consensus Rating of "Hold" by Brokerages
Phreesia, Inc. (NYSE:PHR) has received a consensus "Hold" rating from 19 brokerages, with an average 12-month price target of $16.65. Recent analyst updates show mixed views, with some firms lowering price targets while others maintained buy ratings. The company's latest quarterly earnings exceeded expectations, reporting $0.05 EPS against a $0.02 consensus and a 12.9% year-over-year revenue increase.
Phreesia, Inc. $PHR Stake Lessened by Dimensional Fund Advisors LP
Dimensional Fund Advisors LP reduced its stake in Phreesia, Inc. (NYSE:PHR) by 22.9% in the first quarter, selling 143,563 shares and retaining 484,717 shares valued at $4.07 million. Despite this reduction, institutional investors collectively own 92.1% of the company. Phreesia reported strong Q1 earnings with EPS of $0.05, beating estimates, and a 12.9% year-over-year revenue increase to $130.94 million, while analysts currently rate the stock as a "Hold" with an average price target of $16.65.
AQR Capital discloses 5.1% Phreesia (PHR) ownership in new Schedule 13G
AQR Capital Management, LLC and AQR Capital Management Holdings, LLC have reported a beneficial ownership of 5.1% in Phreesia, Inc. (PHR) through a new Schedule 13G filing. This amounts to 3,151,453 shares of common stock, with both entities sharing voting and dispositive power. The filing indicates a neutral sentiment and moderate impact for Phreesia.
Bronstein, Gewirtz & Grossman, LLC Is Investigating Phreesia, Inc. (PHR) And Encourages Shareholders to Connect
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Phreesia, Inc. (NYSE: PHR) securities who bought prior to March 30, 2026, and still hold their shares. The investigation focuses on whether Phreesia and its officers/directors engaged in corporate wrongdoing. The firm encourages affected shareholders to connect via their website to assist with the investigation, noting there is no cost to investors as they operate on a contingency fee basis.
PHR INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announce
Bronstein, Gewirtz and Grossman, LLC has announced a class action lawsuit against Phreesia, Inc. (NYSE:PHR) and its officers. The lawsuit, filed on behalf of investors who purchased Phreesia securities between May 8, 2025, and March 30, 2026, alleges that the company made materially false and misleading statements regarding slowing demand, diminished visibility into revenue streams, and weakened pharmaceutical marketing commitments in its Network Solutions segment. Investors who suffered losses have until July 13, 2026, to request appointment as lead plaintiff.
Phreesia Inc (PHR) Earnings Forecast: Future EPS & Revenue Growth Estimates
This article provides an earnings forecast for Phreesia Inc (PHR), detailing its current earnings forecast score, average price target from analysts, and a breakdown of analyst ratings. It also includes key financial figures such as expected revenue and EPS for upcoming quarters, alongside a peer comparison. The forecast suggests a positive outlook with most analysts recommending a "Buy" for PHR stock.
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Phreesia, Inc. (PHR) and Encourages Shareholders to Learn More About the Investigation
Bronstein, Gewirtz & Grossman, LLC has launched an investigation into Phreesia, Inc. (NYSE:PHR) concerning potential corporate wrongdoing by the company and its officers/directors. The firm is encouraging shareholders who purchased Phreesia securities before March 30, 2026, and continue to hold them, to learn more and assist with the investigation. The investigation aims to restore investor capital and ensure corporate accountability, with the firm representing investors on a contingency fee basis.
PHR Stockholders Have Opportunity to Lead Phreesia, Inc. Class Ac
Bronstein, Gewirtz & Grossman, LLC has filed a class action lawsuit against Phreesia, Inc. (NYSE:PHR) and certain officers, alleging federal securities law violations. The lawsuit claims that Phreesia made false and misleading statements regarding slowing demand, diminished revenue visibility, and weakened pharmaceutical marketing commitments between May 8, 2025, and March 30, 2026. Investors who suffered losses have until July 13, 2026, to request to be appointed as lead plaintiff.
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Phreesia, Inc. (PHR) and Encourages Investors to Learn More About the Investigation
Bronstein, Gewirtz & Grossman, LLC has initiated an investigation into potential corporate wrongdoing by Phreesia, Inc. (NYSE:PHR). The firm encourages investors who purchased Phreesia securities prior to March 30, 2026, and still hold them, to join the investigation. The firm operates on a contingency fee basis, meaning no upfront cost to investors.
PHR INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announce
Bronstein, Gewirtz and Grossman, LLC announced a class action lawsuit against Phreesia, Inc. (NYSE: PHR) for alleged federal securities law violations. The lawsuit claims Phreesia made false and misleading statements regarding slowing demand, diminished visibility into revenue streams, and weakened pharmaceutical marketing commitments. Investors who purchased Phreesia securities between May 8, 2025, and March 30, 2026, are encouraged to join the lawsuit, with a lead plaintiff deadline of July 13, 2026.
PHREESIA, INC. (NYSE: PHR) SHAREHOLDER INVESTIGATION ALERT:
Bernstein Liebhard LLP is investigating potential breaches of fiduciary duty by directors and officers of Phreesia, Inc. (NYSE: PHR). The firm encourages current Phreesia shareholders who purchased shares before May 8, 2025, to contact them to learn about their legal rights. The investigation aims to determine if Company leadership acted in the best interests of shareholders.
PHR Stockholders Have Rights – If You Lost Money Investing in Phreesia, Inc.
Robbins LLP has filed a class action lawsuit against Phreesia, Inc. (NYSE: PHR) on behalf of investors who purchased shares between May 8, 2025, and March 30, 2026. The lawsuit alleges that Phreesia misled investors about the sustainability of its Network Solutions business growth and its fiscal year 2027 revenue outlook. This claim follows a significant drop in Phreesia's stock price after the company lowered its fiscal year 2027 revenue outlook due to weakening pharmaceutical marketing commitments and reduced visibility into future spending.
Phreesia, Inc. (NYSE: PHR) director takes fee as 377 deferred stock units
Phreesia, Inc. director Lainie Goldstein received 377 deferred stock units (DSUs) on July 31, 2026, as an equity-based director fee in lieu of a cash retainer. These DSUs, valued at $10.73 per share, increase her direct holdings to 70,862 shares. The underlying common stock will be issued 90 days after she leaves the board and has a qualifying separation from service under Section 409A.
Principal Financial Group Inc. Buys 112,516 Shares of Phreesia, Inc. $PHR
Principal Financial Group Inc. increased its stake in Phreesia, Inc. by 213.7% in the first quarter, purchasing an additional 112,516 shares, bringing its total to 165,173 shares valued at $1.38 million. Other institutional investors like Vanguard Group Inc., Granahan Investment Management LLC, and Franklin Resources Inc. also adjusted their holdings. Phreesia exceeded quarterly expectations with adjusted earnings of $0.05 per share and revenue of $130.94 million, though analyst sentiment remains mixed with a consensus "Hold" rating and an average price target of $16.65.
Phreesia, Inc. (PHR) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation
Bronstein, Gewirtz & Grossman, LLC has launched an investigation into potential corporate wrongdoing by Phreesia, Inc. (NYSE: PHR). The firm is encouraging shareholders who purchased Phreesia securities before March 30, 2026, and continue to hold them, to contact them for more information and to assist in the investigation. The investigation aims to restore investor capital and ensure corporate accountability.
How Phreesia Inc. (PHR) Affects Rotational Strategy Timing
This article analyzes Phreesia Inc. (PHR) using AI models to determine its impact on rotational strategy timing. It highlights key findings including shifting near-term sentiment, broader weak alignment, and compelling upside potential due to a lack of resistance levels. The analysis also provides three distinct institutional trading strategies (Position Trading, Momentum Breakout, and Risk Hedging) tailored to different risk profiles, along with a multi-timeframe signal analysis indicating varying signal strengths across different horizons.
How Phreesia Inc. (PHR) Affects Rotational Strategy Timing
This article analyzes Phreesia Inc. (PHR) through AI models to determine its effect on rotational strategy timing. It highlights positive near-term sentiment with a potential shift, and no clear price positioning signal, suggesting choppy conditions. The analysis provides specific trading strategies (Position, Momentum Breakout, Risk Hedging) with entry, target, and stop-loss levels, along with multi-timeframe signal analysis for support and resistance.
Phreesia Number of Employees 2026 | Employee Count & Headcount Data
Phreesia, Inc. (PHR) had approximately 1,778 total employees worldwide as of March 2026, marking a 7.1% decline from 1,914 employees in 2023. The company, which is in the Biotech and Healthcare Services industry, is actively hiring with 57 job postings in 2026, despite a significant reduction in hiring velocity. Its workforce is primarily concentrated in North America, and the average salary is $91,777.
PHR|Phreesia Inc|Price:10.740|Chg%:+0.130
Phreesia Inc (PHR) shows relatively healthy fundamentals with high growth potential, and its valuation is considered fairly valued. Despite average stock market performance, the company has turned profitable, and institutional ownership is very high. Analysts have rated it as a Buy, expecting an upward trend in the medium term.
Law firm investigates Phreesia directors for possible breaches of fiduciary duty
Bernstein Liebhard LLP is investigating whether Phreesia, Inc.'s directors and officers breached their fiduciary duties to shareholders. The investigation seeks to determine if the company's leadership acted in the best interests of shareholders and if legal action against them is warranted. Shareholders who purchased stock before May 8, 2025, are encouraged to contact the law firm for a confidential consultation regarding this matter.
